PTH and kidney disorder: For biochemical abnormalities, the Kidney Disease Improving Global Outcomes (KDIGO) guidelines 2017 recommend regular monitoring of serum calcium, phosphate, parathyroid hormone (PTH) and alkaline phosphatase (ALP) starting from CKD stage 3.